920 related articles for article (PubMed ID: 8534728)
1. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
2. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).
Schaefer F; Klaus G; Müller-Wiefel DE; Mehls O
J Am Soc Nephrol; 1999 Jan; 10(1):136-45. PubMed ID: 9890319
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Gray HH; Goulding S; Eykyn SJ
Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227
[TBL] [Abstract][Full Text] [Related]
4. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Gucek A; Bren AF; Hergouth V; Lindic J
Adv Perit Dial; 1997; 13():218-20. PubMed ID: 9360685
[TBL] [Abstract][Full Text] [Related]
5. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J
Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
[TBL] [Abstract][Full Text] [Related]
8. Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Szeto CC; Kwan BC; Chow KM; Law MC; Pang WF; Chung KY; Leung CB; Li PK
Am J Kidney Dis; 2009 Oct; 54(4):702-10. PubMed ID: 19577352
[TBL] [Abstract][Full Text] [Related]
9. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis.
Zurowska A; Feneberg R; Warady BA; Zimmering M; Monteverde M; Testa S; Calyskan S; Drozdz D; Salusky I; Kemper MJ; Ekim M; Verrina E; Misselwitz J; Schaefer F
Am J Kidney Dis; 2008 Mar; 51(3):455-62. PubMed ID: 18295061
[TBL] [Abstract][Full Text] [Related]
10. Peritonitis in children undergoing dialysis. 10 years experience.
Levy M; Balfe JW; Geary DF; Fryer-Keene SP; Bannatyne RM
Child Nephrol Urol; 1988-1989; 9(5):253-8. PubMed ID: 3271590
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
[TBL] [Abstract][Full Text] [Related]
12. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
Sisterhen LL; Stowe CD; Farrar HC; Blaszak CK; Blaszak RT
Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
[TBL] [Abstract][Full Text] [Related]
13. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
Møller JK; Hagelskjaer LH
Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
[TBL] [Abstract][Full Text] [Related]
14. Treatment of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
Horton MW; Deeter RG; Sherman RA
Clin Pharm; 1990 Feb; 9(2):102-18. PubMed ID: 2407420
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of intraperitoneally administered gentamicin and rifampin as initial treatment of peritoneal dialysis-related peritonitis.
Brulez HF; Moncasi EP; Posthuma N; Choy K; ter Wee PM
Adv Perit Dial; 1995; 11():182-6. PubMed ID: 8534700
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis.
Lye WC; Wong PL; van der Straaten JC; Leong SO; Lee EJ
Adv Perit Dial; 1995; 11():179-81. PubMed ID: 8534699
[TBL] [Abstract][Full Text] [Related]
17. Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.
Heywood A; Bargman JM
Adv Perit Dial; 2010; 26():34-6. PubMed ID: 21348376
[TBL] [Abstract][Full Text] [Related]
18. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes.
Barraclough K; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Johnson DW
Am J Kidney Dis; 2010 Jan; 55(1):121-31. PubMed ID: 19932543
[TBL] [Abstract][Full Text] [Related]
19. Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis.
Tong MK; Leung KT; Siu YP; Lee KF; Lee HK; Yung CY; Kwan TH; Au TC
J Nephrol; 2005; 18(2):204-8. PubMed ID: 15931649
[TBL] [Abstract][Full Text] [Related]
20. [Peritonitis in continuous ambulatory peritoneal dialysis. An evaluation of the empiric initial antibiotic treatment].
Hagelskjaer LH; Møller JK
Ugeskr Laeger; 1996 Apr; 158(18):2532-7. PubMed ID: 8686006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
